ED
CMCSK

Exane Derivatives’s COMCAST CORP SPL A (NEW) CMCSK Stock Holding History

Exane Derivatives’s Portfolio CMCSK Stock Details CMCSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-391,226
Closed -$23.4M – 586
2015
Q2 		$23.4M Buy
+391,226
New +$23.4M 2.52% 10
2015
Q1 		– Sell
-223,498
Closed -$12.9M – 579
2014
Q4 		$12.9M Buy
+223,498
New +$12.9M 1.78% 22

Other funds holding CMCSK

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Exane Derivatives's CMCSK Position: Q3 2015 in Review

Exane Derivatives sold out of COMCAST CORP SPL A (NEW) (CMCSK) in Q3 2015, closing a stake of 391,226 shares — an estimated $23.4M sold.

Exane Derivatives first reported a position in CMCSK in Q4 2014 and held it in 2 quarters. The position peaked at $23.4M in Q2 2015. 552 funds tracked by Wall St. Rank hold CMCSK as of Q3 2015.

  • Exane Derivatives reported no remaining COMCAST CORP SPL A (NEW) position as of Q3 2015 after selling out during the quarter.
  • Exane Derivatives sold 391,226 COMCAST CORP SPL A (NEW) shares in Q3 2015, an estimated $23.4M.
  • Exane Derivatives first reported a position in COMCAST CORP SPL A (NEW) in Q4 2014 and held it in 2 quarters.
  • Exane Derivatives's COMCAST CORP SPL A (NEW) position peaked at $23.4M in Q2 2015.
  • 552 funds tracked by Wall St. Rank held COMCAST CORP SPL A (NEW) as of Q3 2015.

Based on Exane Derivatives's 13F filing for Q3 2015, filed 13 Nov 2015.